SCHEMBL4069878

SCHEMBL4069878

CC(C)(C)c1ccc(S(=O)(=O)Nc2cnc3[nH]c(C(=O)O)c(-c4cccs4)c3c2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.45
BRD4 O60885 1/20 0.43
UQCRB P14927 2/20 0.43
SERPINE1 P05121 1/20 0.42
IKBKB O14920 1/20 0.41
ALDH1A1 P00352 4/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
HTT P42858 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
KEAP1 Q14145 1/20 0.41
NFE2L2 Q16236 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4922521 0.87 BRD4 (0.54) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL4069882 0.87 BRD4 (0.42) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL3957017 0.86 SERPINE1 (0.54) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL4071552 0.85 SERPINE1 (0.44) SERPINE1MEN1KMT2AMAPTHDAC3
SCHEMBL4077703 0.85 PTPN5 (0.45) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL4142667 0.84 BRD4 (0.37) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL4142664 0.84 BRD4 (0.37) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL4142596 0.81 GAA (0.48) ALDH1A1POLBMEN1KMT2ANPSR1
SCHEMBL4072961 0.80 PTPN5 (0.45) PTPN5BRD4UQCRBSERPINE1IKBKB
SCHEMBL13910226 0.80 SERPINE1 (0.51) PTPN5BRD4UQCRBSERPINE1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2036906-A1 Azaindoles as inhibitors of soluble adenylate cyclase Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-18 EP claimed
EP-2036906-A1 Azaindoles as inhibitors of soluble adenylate cyclase Bayer Schering Pharma Aktiengesellschaft (DE) 2009-03-18 EP disclosed